.

Sunday, December 22, 2013

Novartis Review

Novartis Novartis AG Latest results: Country: Sector: Bloomberg Ticker: Q4 2010 Switzerland drug company NVS.OL Industry view: connection view: Company military rating: Risk Quality Valuation spoil the complete reputation Buy the complete Report busted MED. HIGH - - - Indigo Equity look Limited info@indigo-equity-research.com www.indigo-equity-research.com 15 Feb 2011 Investment Profile Note that this is a shortstop version of a more complete (6 page) base on Novartis. Executive Summary Novartis has the profile of a mettlesome quality, ripe and reliable company. This is a reflection of Novartis having grown revenues, EPS and dividends relatively consistently over the last ten years, with stable avail margins. geartrain is low and cash flow is strong. As a value short letter the high dividend yield is crucial to its valuation. Overall, Novartis has performed well compared to its peers and given up the negative pharma industry trends. Critically, it ha s mostly avoided major juridic proceeding & PR disasters of that other pharma companies have had. It is operationally diversify with pharma, vaccines & diagnostics, generics, and consumer health divisions.
Ordercustompaper.com is a professional essay writing service at which you can buy essays on any topics and disciplines! All custom essays are written by professional writers!
Buy the complete report for more enlarge package bell - Last 10 years 70 60 50 USD 40 30 20 10 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 0 NOVARTIS S&P 500 (Rebased) swell Structure partake Price Number of Shares (bn) Market capitalization electronic network (Debt) / Cash nonage Interests & Prefs Enterprise Value (EV) authorize Debt / Market Cap. Financial Results y/e 31 regrets Sales EBIT Net Income Share Capital Total a! dditions FCF Per Share Data EPS DPS Cash EPS BV strength analysis EBIT Margin Net Profit Margin Asset Turnover Net appurtenance** ($) ($) ($) ($) 2010 ($ Bn) 50.6 11.5 9.8 63.2 123.3 11.8 2010 4.28 2.20 5.18 27.64 2010 22.8 % 19.3 % 41.1 % 195.1 % Per Share ($) 55.9 Total ($ Bn) 2.3 127.9 -14.9 142.8 12% 2012e ($ Bn) 60.2 9.8 7.6 69.0 129.9 8.3 2012e 3.32 2.84 3.61 30.20 2012e 16.3 % 12.6 % 46.3 % 188.1 % 11.0 % 2012e...If you want to get a full essay, order it on our website: OrderCustomPaper.com

If you want to get a full essay, visit our page: write my paper

No comments:

Post a Comment